Nutritional Counseling in Children with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: Analysis of Growth Response Parameters. [PDF]
Budzulak J, Majewska KA, Kędzia A.
europepmc +1 more source
Synthetic polypeptides using a biologic as a reference medicinal product - the European landscape of regulatory approvals. [PDF]
Klein K, Heisterberg J, Stolk P.
europepmc +1 more source
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution? [PDF]
Chatzimichail E +3 more
europepmc +1 more source
Evaluating biosimilars: safety, efficacy, and regulatory considerations in clinical studies. [PDF]
Liu Y +6 more
europepmc +1 more source
Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis. [PDF]
Shan H +5 more
europepmc +1 more source
A Regulatory Perspective on Biosimilar Medicines. [PDF]
Cordeiro MA +3 more
europepmc +1 more source
BMI z-score as a prognostic factor for height velocity in children treated with recombinant human growth hormone due to idiopathic growth hormone deficiency. [PDF]
Budzulak J, Majewska KA, Kędzia A.
europepmc +1 more source

